Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124082702 | 12408270 | 2 | F | 20160408 | 20160821 | 20160526 | 20160901 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-041092 | BRISTOL MYERS SQUIBB | 66.00 | YR | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124082702 | 12408270 | 1 | PS | BELATACEPT | BELATACEPT | 1 | Intravenous (not otherwise specified) | 400 MG, Q2WK | 125288 | 400 | MG | INJECTION | QOW | ||||||
124082702 | 12408270 | 2 | SS | BELATACEPT | BELATACEPT | 1 | Intravenous (not otherwise specified) | UNK, Q4WK | 125288 | INJECTION | |||||||||
124082702 | 12408270 | 3 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | U | 0 | 1000 | MG | BID | ||||||
124082702 | 12408270 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
124082702 | 12408270 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
124082702 | 12408270 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
124082702 | 12408270 | 7 | C | CALCITROL /00508501/ | CALCIUM CARBONATEERGOCALCIFEROLRETINOL | 1 | Oral | 0.25 ?G, Q2WK | U | 0 | .25 | UG | QOW | ||||||
124082702 | 12408270 | 8 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 500 MG, BID | 0 | 500 | MG | BID | |||||||
124082702 | 12408270 | 9 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | Oral | 1 TAB, QD | 0 | 1 | DF | QD | |||||||
124082702 | 12408270 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, UNK | 0 | 40 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124082702 | 12408270 | 1 | Renal transplant |
124082702 | 12408270 | 3 | Renal transplant |
124082702 | 12408270 | 4 | Renal transplant |
124082702 | 12408270 | 5 | Product used for unknown indication |
124082702 | 12408270 | 6 | Product used for unknown indication |
124082702 | 12408270 | 7 | Product used for unknown indication |
124082702 | 12408270 | 8 | Product used for unknown indication |
124082702 | 12408270 | 9 | Product used for unknown indication |
124082702 | 12408270 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124082702 | 12408270 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124082702 | 12408270 | Leukopenia | |
124082702 | 12408270 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124082702 | 12408270 | 1 | 20160401 | 0 | ||
124082702 | 12408270 | 2 | 20160530 | 0 | ||
124082702 | 12408270 | 3 | 20130305 | 0 | ||
124082702 | 12408270 | 4 | 20130305 | 0 | ||
124082702 | 12408270 | 5 | 20130427 | 0 | ||
124082702 | 12408270 | 6 | 20130306 | 0 | ||
124082702 | 12408270 | 7 | 20130319 | 0 | ||
124082702 | 12408270 | 8 | 20150306 | 0 | ||
124082702 | 12408270 | 9 | 20130305 | 0 | ||
124082702 | 12408270 | 10 | 20121017 | 0 |